AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
On December 20 the FDA approved the first new treatment for schizophrenia since 2003, the atypical antipsychotic Invega (paliperidone) extended-release. Paliperidone is the principal active metabolite of risperidone. It is the first atypical antipsychotic to use the OROS[R]…